Open Access
REVIEW
Jiayu Zou1,2,3, Yajie Lu3, Jiaqi Li3, Zhaokai Zhou4,5, Fu Peng3, Pu Qiu2,*, Hailin Tang6, Cheng Peng1,*
1 State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China
2 Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Guangzhou, 511436, China
3 Department of Pharmacology, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, 610041, China
4 Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, 410011, China
5 National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, 410011, China
6 State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China
* Corresponding Author: Pu Qiu. Email: ; Cheng Peng. Email:
Oncology Research https://doi.org/10.32604/or.2025.071940
Received 16 August 2025; Accepted 21 November 2025; Published online 23 December 2025
View
Download
Like
Macrophage-derived SHP-2 inhibits the metastasis of colorectal cancer via Tie2-PI3K signals
XUELIANG WU, SHAOYU GUAN, YONGGANG...The role of LIN28B in tumor progression and metastasis in solid tumor entities
TABEA GEWALT, KA-WON NOH, LYDIA...